Binding of prostaglandins to human PPARγ: Tool assessment and new natural ligands

European Journal of Pharmacology

Volumn 417, Issue 1-2, 2001, Pages 77-89

  Ferry, Gilles ^a   Bruneau, Vincent ^a   Beauverger, Philippe ^a   Goussard, Marion ^a   Rodriguez, Marianne ^a   Lamamy, Véronique ^a   Dromaint, Sandra ^a   Canet, Emmanuel ^a   Galizzi, Jean Pierre ^a   Boutin, Jean A ^a  

^a INSTITUT DE RECHERCHES SERVIER   (France)

Author keywords

Glutathione S transferase fusion protein; PPAR ; PPAR ligand, naturally occurring; Prostaglandin H1; Prostaglandin H2; Transactivation

Indexed keywords

BEZAFIBRATE; CELL NUCLEUS RECEPTOR; CIGLITAZONE; CLOFIBRATE; GLUTATHIONE TRANSFERASE; HYBRID PROTEIN; MEMBRANE PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN H; PROSTAGLANDIN H2; PROSTAGLANDIN J2; RADIOLIGAND; RECEPTOR BLOCKING AGENT; ROSIGLITAZONE;

ADIPOSE TISSUE; ARTICLE; BACTERIAL MEMBRANE; BINDING COMPETITION; CARCINOGENESIS; ESCHERICHIA COLI; GENE ACTIVATION; GENE EXPRESSION; HUMAN; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; TRANSACTIVATION;

BINDING SITES; BINDING, COMPETITIVE; ESCHERICHIA COLI; GLUTATHIONE TRANSFERASE; HUMANS; KINETICS; LIGANDS; MEMBRANES; PROSTAGLANDINS; RADIOLIGAND ASSAY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECOMBINANT FUSION PROTEINS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS;

EID: 0035815269     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(01)00907-4     Document Type: Article

References (61)

1. A systematic analytical/cell assay approach to isolate activators of orphan nuclear receptors from biological extracts: Characterization of peroxisome proliferator-activated receptor activators in plasma
2. PPARγ is required for placental, cardiac and adipose tissue development
3. Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-γ: Binding and activation correlate with antidiabetic actions in db/db mice
4. 2
5. Identification of peroxisome proliferator-activated receptor ligands from a biased chemical library
6. Peroxisome proliferator-activated receptor (PPAR) gamma: Adipose-predominant expression and induction early in adipocyte differentiation
7. 2 and 15-deoxy-Δ12,14-prostaglandin J2 induce proliferation of cyclooxygenase-depleted colorectal cancer cells
8. N-(2-benzoylphenyl)-L-tyrosine PPARγ: 3. Structure-activity relationship and optimization of the N-aryl substituent
9. Peroxisome proliferator-activated receptors: Nuclear control of metabolism
10. Ligand induced peroxisome proliferator-activated receptor α conformational change
11. Ligands for peroxisome proliferator-activated receptor γ and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice
12. 15-deoxy-Δ12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
13. Hypolipidemic drugs, polyunsaturated fatty acids and eicosamoids are ligands for peroxisome proliferator-activated receptors α and δ
14. Biological activities and mechanisms of action of prostaglandin J2 and related compounds: An update
15. Orphan nuclear receptors: From gene to function
16. Fatty acids activate a chimera of the clofibric acid-activated receptor and glucocorticoid receptor
17. 2 in transformed endothelial cells
18. Feedback control of cyclooxygenase-2 expression through PPARγ
19. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
20. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines
21. 2, a ligand for peroxisome proliferator-activated receptor-γ, induces apoptosis in JEG3 choriocarcinoma cells
22. Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers
23. Convergence of 9-cis retinoic acid and peroxisome proliferator signaling pathways through heterodimer formation of their receptors
24. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation
25. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma
26. Fatty acids, eicosanoids and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by co-activator-dependent receptor ligand assay
27. PPARγ mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance
28. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
29. min/+ mice
30. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPAR γ)
31. Peroxisome proliferator-activated receptors α and γ are activated by indomethacin and other non-steroidal anti-inflammatory drugs
32. Ligand-induced alteration of the protease sensitivity of retinoid X receptor α
33. PPARγ: An essential regulator of adipogenesis and modulator of fat cell function
34. Characterization of synthetic tritium-labeled peroxisome proliferator-activated receptor (hPPAR-γ) ligand
35. The 15-deoxy-Δ12,14-prostaglandin J2 receptor, peroxisome proliferator activated-receptor-γ (PPARγ) is expressed in human gestational tissues and is functionally active in JEG3 choriocarcinoma cells
36. Biological activites of prostaglandin H1 analogs
37. Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists
38. A selective peroxisome-activated receptor-γ (PPARγ) modulator blocks adipocyte differentiation but stimulates glucose uptake inb 3T3-L1 adipocytes
39. Development of a scintillation proximity assay for peroxisome proliferator-activated receptor γ ligand binding domain
40. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation
41. Peroxisome proliferator-activated receptor-γ: A versatile metabolic regulator
42. PPARγ is required for the differentiation of adipose tissue in vivo and in vitro
43. Anti-inflammatory cyclopentenione prostaglandins are direct inhibitors of IκB kinase
44. Activators of the nuclear receptor PPARγ enhance colon polyp formation
45. Differentiation and reversal of malignant changes in colon cancer through PPARγ
46. Peroxisome proliferator-activated receptors, orphans with ligands and functions
47. Transactivation by retinoid X receptor-peroxisome proliferator-activated receptor γ (PPARγ) heterodimers: Intermolecular synergy requires only the PPARγ hormone dependent activation function
48. Regulation of peroxisome proliferator-activated receptors
49. PPARγ: Adipogenic regulator and thiazolidinedione receptor
50. A new ligand for the peroxisome proliferator-activated receptor-γ (PPAR-γ), GW7845, inhibits rat mammary carcinogenesis
51. Cyclooxygenase-2 inhibitors in tumorigenesis
52. mPPAR γ 2: Tissue-specific regulator of an adipocyte enhancer
53. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor
54. Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor
55. Medical significance of peroxisome proliferator-activated receptors
56. Peroxisome proliferator-activated receptors: A critical link among fatty acids, gene expression and carcinogenesis
57. The PPARs: From orphan receptors to drug discovery
58. Peroxisome proliferator-activated receptor γ ligands are potent inhibitors of angiogenesis in vitro and in vivo
59. Molecular recognition of fatty acids by peroxisome proliferator-activated receptors
60. Identification of high-affinity binding sites for the insulin sensitizer rosiglitazone in rodent and human adipocytes using a radioionated ligand for peroxisome proliferator-activated receptor γ
61. Differential activation of peroxisome proliferator-activated receptors by eicosanoids